Review



e coli jm109  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    ATCC e coli jm109
    Growth of bacterial biofilms in the MBEC assay . (A) Mean cell density of Pseudomonas aeruginosa ATCC 27853 biofilms on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.842 using one-way ANOVA). (B) SEM photomicrograph of a P. aeruginosa biofilm on the peg surface. (C) Mean cell density of <t>Escherichia</t> <t>coli</t> TG1 on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.274 using one-way ANOVA). (D) SEM photomicrograph of an E. coli biofilm on the peg surface. The bar represents 5 μm.
    E Coli Jm109, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli jm109/product/ATCC
    Average 91 stars, based on 1 article reviews
    e coli jm109 - by Bioz Stars, 2025-07
    91/100 stars

    Images

    1) Product Images from "High-throughput metal susceptibility testing of microbial biofilms"

    Article Title: High-throughput metal susceptibility testing of microbial biofilms

    Journal: BMC Microbiology

    doi: 10.1186/1471-2180-5-53

    Growth of bacterial biofilms in the MBEC assay . (A) Mean cell density of Pseudomonas aeruginosa ATCC 27853 biofilms on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.842 using one-way ANOVA). (B) SEM photomicrograph of a P. aeruginosa biofilm on the peg surface. (C) Mean cell density of Escherichia coli TG1 on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.274 using one-way ANOVA). (D) SEM photomicrograph of an E. coli biofilm on the peg surface. The bar represents 5 μm.
    Figure Legend Snippet: Growth of bacterial biofilms in the MBEC assay . (A) Mean cell density of Pseudomonas aeruginosa ATCC 27853 biofilms on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.842 using one-way ANOVA). (B) SEM photomicrograph of a P. aeruginosa biofilm on the peg surface. (C) Mean cell density of Escherichia coli TG1 on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.274 using one-way ANOVA). (D) SEM photomicrograph of an E. coli biofilm on the peg surface. The bar represents 5 μm.

    Techniques Used: Standard Deviation

    Susceptibility of  Escherichia coli JM109  to metal cations with 2 or 24 h of exposure in rich (LB + B1) medium
    Figure Legend Snippet: Susceptibility of Escherichia coli JM109 to metal cations with 2 or 24 h of exposure in rich (LB + B1) medium

    Techniques Used:

    Susceptibility of  Escherichia coli JM109  to metal cations with 2 or 24 h of exposure in minimal (MSVG) medium
    Figure Legend Snippet: Susceptibility of Escherichia coli JM109 to metal cations with 2 or 24 h of exposure in minimal (MSVG) medium

    Techniques Used:

    Potential neutralizing agents for the microbiological application of inactivating metals cations and oxyanions*
    Figure Legend Snippet: Potential neutralizing agents for the microbiological application of inactivating metals cations and oxyanions*

    Techniques Used:



    Similar Products

    91
    ATCC e coli jm109
    Growth of bacterial biofilms in the MBEC assay . (A) Mean cell density of Pseudomonas aeruginosa ATCC 27853 biofilms on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.842 using one-way ANOVA). (B) SEM photomicrograph of a P. aeruginosa biofilm on the peg surface. (C) Mean cell density of <t>Escherichia</t> <t>coli</t> TG1 on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.274 using one-way ANOVA). (D) SEM photomicrograph of an E. coli biofilm on the peg surface. The bar represents 5 μm.
    E Coli Jm109, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/e coli jm109/product/ATCC
    Average 91 stars, based on 1 article reviews
    e coli jm109 - by Bioz Stars, 2025-07
    91/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology shrna plasmid against nudt21 targeting 5 acctcctcagtatccatat
    Expression levels of <t>NUDT21</t> in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.
    Shrna Plasmid Against Nudt21 Targeting 5 Acctcctcagtatccatat, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/shrna plasmid against nudt21 targeting 5 acctcctcagtatccatat/product/Santa Cruz Biotechnology
    Average 91 stars, based on 1 article reviews
    shrna plasmid against nudt21 targeting 5 acctcctcagtatccatat - by Bioz Stars, 2025-07
    91/100 stars
      Buy from Supplier

    91
    ATCC vector pdk101 t
    Expression levels of <t>NUDT21</t> in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.
    Vector Pdk101 T, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/vector pdk101 t/product/ATCC
    Average 91 stars, based on 1 article reviews
    vector pdk101 t - by Bioz Stars, 2025-07
    91/100 stars
      Buy from Supplier

    91
    Santa Cruz Biotechnology gene knockdown specif ic shrna plasmid against nudt21 targeting 5 acctcctcagtatccatat
    Expression levels of <t>NUDT21</t> in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.
    Gene Knockdown Specif Ic Shrna Plasmid Against Nudt21 Targeting 5 Acctcctcagtatccatat, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/gene knockdown specif ic shrna plasmid against nudt21 targeting 5 acctcctcagtatccatat/product/Santa Cruz Biotechnology
    Average 91 stars, based on 1 article reviews
    gene knockdown specif ic shrna plasmid against nudt21 targeting 5 acctcctcagtatccatat - by Bioz Stars, 2025-07
    91/100 stars
      Buy from Supplier

    86
    Halliburton Energy Services tx 77406
    Expression levels of <t>NUDT21</t> in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.
    Tx 77406, supplied by Halliburton Energy Services, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tx 77406/product/Halliburton Energy Services
    Average 86 stars, based on 1 article reviews
    tx 77406 - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    86
    Petrotech Inc tx 77406
    Expression levels of <t>NUDT21</t> in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.
    Tx 77406, supplied by Petrotech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tx 77406/product/Petrotech Inc
    Average 86 stars, based on 1 article reviews
    tx 77406 - by Bioz Stars, 2025-07
    86/100 stars
      Buy from Supplier

    91
    ATCC ta vector modified pdk 101
    Expression levels of <t>NUDT21</t> in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.
    Ta Vector Modified Pdk 101, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ta vector modified pdk 101/product/ATCC
    Average 91 stars, based on 1 article reviews
    ta vector modified pdk 101 - by Bioz Stars, 2025-07
    91/100 stars
      Buy from Supplier

    91
    ATCC plasmid pdk101
    Expression levels of <t>NUDT21</t> in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.
    Plasmid Pdk101, supplied by ATCC, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/plasmid pdk101/product/ATCC
    Average 91 stars, based on 1 article reviews
    plasmid pdk101 - by Bioz Stars, 2025-07
    91/100 stars
      Buy from Supplier

    Image Search Results


    Growth of bacterial biofilms in the MBEC assay . (A) Mean cell density of Pseudomonas aeruginosa ATCC 27853 biofilms on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.842 using one-way ANOVA). (B) SEM photomicrograph of a P. aeruginosa biofilm on the peg surface. (C) Mean cell density of Escherichia coli TG1 on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.274 using one-way ANOVA). (D) SEM photomicrograph of an E. coli biofilm on the peg surface. The bar represents 5 μm.

    Journal: BMC Microbiology

    Article Title: High-throughput metal susceptibility testing of microbial biofilms

    doi: 10.1186/1471-2180-5-53

    Figure Lengend Snippet: Growth of bacterial biofilms in the MBEC assay . (A) Mean cell density of Pseudomonas aeruginosa ATCC 27853 biofilms on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.842 using one-way ANOVA). (B) SEM photomicrograph of a P. aeruginosa biofilm on the peg surface. (C) Mean cell density of Escherichia coli TG1 on the pegs in different rows of the MBEC assay. Each value is expressed as the mean and standard deviation of 4 to 6 trials. There is no significant difference between cell density of biofilms in the different rows ( p = 0.274 using one-way ANOVA). (D) SEM photomicrograph of an E. coli biofilm on the peg surface. The bar represents 5 μm.

    Article Snippet: Escherichia coli TG1, E. coli JM109 and Pseudomonas aeruginosa ATCC 27853 were stored at -70°C in Cryobanks™ (Prolab Diagnostics) according to the manufacturer's instructions.

    Techniques: Standard Deviation

    Susceptibility of  Escherichia coli JM109  to metal cations with 2 or 24 h of exposure in rich (LB + B1) medium

    Journal: BMC Microbiology

    Article Title: High-throughput metal susceptibility testing of microbial biofilms

    doi: 10.1186/1471-2180-5-53

    Figure Lengend Snippet: Susceptibility of Escherichia coli JM109 to metal cations with 2 or 24 h of exposure in rich (LB + B1) medium

    Article Snippet: Escherichia coli TG1, E. coli JM109 and Pseudomonas aeruginosa ATCC 27853 were stored at -70°C in Cryobanks™ (Prolab Diagnostics) according to the manufacturer's instructions.

    Techniques:

    Susceptibility of  Escherichia coli JM109  to metal cations with 2 or 24 h of exposure in minimal (MSVG) medium

    Journal: BMC Microbiology

    Article Title: High-throughput metal susceptibility testing of microbial biofilms

    doi: 10.1186/1471-2180-5-53

    Figure Lengend Snippet: Susceptibility of Escherichia coli JM109 to metal cations with 2 or 24 h of exposure in minimal (MSVG) medium

    Article Snippet: Escherichia coli TG1, E. coli JM109 and Pseudomonas aeruginosa ATCC 27853 were stored at -70°C in Cryobanks™ (Prolab Diagnostics) according to the manufacturer's instructions.

    Techniques:

    Potential neutralizing agents for the microbiological application of inactivating metals cations and oxyanions*

    Journal: BMC Microbiology

    Article Title: High-throughput metal susceptibility testing of microbial biofilms

    doi: 10.1186/1471-2180-5-53

    Figure Lengend Snippet: Potential neutralizing agents for the microbiological application of inactivating metals cations and oxyanions*

    Article Snippet: Escherichia coli TG1, E. coli JM109 and Pseudomonas aeruginosa ATCC 27853 were stored at -70°C in Cryobanks™ (Prolab Diagnostics) according to the manufacturer's instructions.

    Techniques:

    Expression levels of NUDT21 in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.

    Journal: Cancer Management and Research

    Article Title: Knockdown of NUDT21 inhibits proliferation and promotes apoptosis of human K562 leukemia cells through ERK pathway

    doi: 10.2147/CMAR.S173496

    Figure Lengend Snippet: Expression levels of NUDT21 in human leukemia. Notes: ( A ) mRNA expression levels of NUDT21 in bone marrow samples from healthy control subjects (HC1–HC15) and CML patients (P1–P15). The mRNA ( B ) expression levels of NUDT21 were evaluated by qRT-PCR in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. The protein ( C and D ) expression levels of NUDT21 were evaluated by Western blotting in human normal PBMCs, human leukemia cells K562, Jurkat, and hl-60 cells. GAPDH was used as internal control; the data are the mean ± SD for duplicate experiments. *** P < 0.001. Abbreviations: CML, chronic myelocytic leukemia; HC, healthy control; qRT-PCR, quantitative reverse polymerase chain reaction.

    Article Snippet: Specific shRNA plasmid against NUDT21 targeting 5′-ACCTCCTCAGTATCCATAT-3′ and a non-silencing shRNA control plasmid targeting 5′-TTCTCCGAACGT-GTCACGT-3′ were synthesized by Santa Cruz Biotechnology Inc.

    Techniques: Expressing, Quantitative RT-PCR, Western Blot, Polymerase Chain Reaction

    Knockdown of NUDT21 in leukemia cells. Notes: Western blotting ( A and B ) and qPCR ( C ) were used to confirm the knockdown effects of shRNAs against NUDT21 in K562, Jurkat and HL-60 cells. The data are the mean ± SD for duplicate experiments; *** P <0.001. Abbreviation: qRT-PCR, quantitative reverse polymerase chain reaction.

    Journal: Cancer Management and Research

    Article Title: Knockdown of NUDT21 inhibits proliferation and promotes apoptosis of human K562 leukemia cells through ERK pathway

    doi: 10.2147/CMAR.S173496

    Figure Lengend Snippet: Knockdown of NUDT21 in leukemia cells. Notes: Western blotting ( A and B ) and qPCR ( C ) were used to confirm the knockdown effects of shRNAs against NUDT21 in K562, Jurkat and HL-60 cells. The data are the mean ± SD for duplicate experiments; *** P <0.001. Abbreviation: qRT-PCR, quantitative reverse polymerase chain reaction.

    Article Snippet: Specific shRNA plasmid against NUDT21 targeting 5′-ACCTCCTCAGTATCCATAT-3′ and a non-silencing shRNA control plasmid targeting 5′-TTCTCCGAACGT-GTCACGT-3′ were synthesized by Santa Cruz Biotechnology Inc.

    Techniques: Western Blot, Quantitative RT-PCR, Polymerase Chain Reaction

    K562 cell growth upon knockdown of NUDT21. Notes: ( A ) Proliferation capabilities were detected by CCK-8 in K562, Jurkat, and HL-60 cells (2×10 3 ) for 5 days after transfection of shRNA control or NUDT21 shRNA. ( B ) K562 cells were transfected with shRNA control or NUDT21 shRNA for 48 hours and re-seeded in 96-well plate for BrdU assays. ( C ) Cell cycle phase distributions were detected by flow cytometry in K562 cells after transfection of shRNA control or NUDT21 shRNA. ( D ) Western blotting analysis of the protein expressions of PCNA and cyclin E after transfection of shRNA control or NUDT21 shRNA. The data are expressed as mean ± SD for duplicate experiments. * P <0.05; ** P <0.01; *** P <0.001. Abbreviations: CCK-8, Cell Counting Kit-8; BrdU, bromodeoxyuridine.

    Journal: Cancer Management and Research

    Article Title: Knockdown of NUDT21 inhibits proliferation and promotes apoptosis of human K562 leukemia cells through ERK pathway

    doi: 10.2147/CMAR.S173496

    Figure Lengend Snippet: K562 cell growth upon knockdown of NUDT21. Notes: ( A ) Proliferation capabilities were detected by CCK-8 in K562, Jurkat, and HL-60 cells (2×10 3 ) for 5 days after transfection of shRNA control or NUDT21 shRNA. ( B ) K562 cells were transfected with shRNA control or NUDT21 shRNA for 48 hours and re-seeded in 96-well plate for BrdU assays. ( C ) Cell cycle phase distributions were detected by flow cytometry in K562 cells after transfection of shRNA control or NUDT21 shRNA. ( D ) Western blotting analysis of the protein expressions of PCNA and cyclin E after transfection of shRNA control or NUDT21 shRNA. The data are expressed as mean ± SD for duplicate experiments. * P <0.05; ** P <0.01; *** P <0.001. Abbreviations: CCK-8, Cell Counting Kit-8; BrdU, bromodeoxyuridine.

    Article Snippet: Specific shRNA plasmid against NUDT21 targeting 5′-ACCTCCTCAGTATCCATAT-3′ and a non-silencing shRNA control plasmid targeting 5′-TTCTCCGAACGT-GTCACGT-3′ were synthesized by Santa Cruz Biotechnology Inc.

    Techniques: CCK-8 Assay, Transfection, shRNA, Flow Cytometry, Western Blot, Cell Counting

    K562 cell apoptosis upon knockdown of NUDT21. Notes: ( A ) The activities of Caspase3/7 were determined by Caspase-Glo 3/7 assays in K562 cells (1.5×10 4 ) after transfection of shRNA control or NUDT21 shRNA. ( B ) The percentage of annexin V-positive revealed apoptosis. Percentages of cells undergoing apoptosis in different groups are shown. ( C and D ) Bax and Bcl-2 protein were determined by Western blot analysis in K562 cells after transfection of shRNA control or NUDT21 shRNA. Data are expressed as mean ± SD for duplicate experiments. ** P <0.01; *** P <0.001. Abbreviation: PI, propidium iodide.

    Journal: Cancer Management and Research

    Article Title: Knockdown of NUDT21 inhibits proliferation and promotes apoptosis of human K562 leukemia cells through ERK pathway

    doi: 10.2147/CMAR.S173496

    Figure Lengend Snippet: K562 cell apoptosis upon knockdown of NUDT21. Notes: ( A ) The activities of Caspase3/7 were determined by Caspase-Glo 3/7 assays in K562 cells (1.5×10 4 ) after transfection of shRNA control or NUDT21 shRNA. ( B ) The percentage of annexin V-positive revealed apoptosis. Percentages of cells undergoing apoptosis in different groups are shown. ( C and D ) Bax and Bcl-2 protein were determined by Western blot analysis in K562 cells after transfection of shRNA control or NUDT21 shRNA. Data are expressed as mean ± SD for duplicate experiments. ** P <0.01; *** P <0.001. Abbreviation: PI, propidium iodide.

    Article Snippet: Specific shRNA plasmid against NUDT21 targeting 5′-ACCTCCTCAGTATCCATAT-3′ and a non-silencing shRNA control plasmid targeting 5′-TTCTCCGAACGT-GTCACGT-3′ were synthesized by Santa Cruz Biotechnology Inc.

    Techniques: Transfection, shRNA, Western Blot

    Deregulation of signaling pathways upon knockdown of NUDT21. Notes: ( A ) Heatmap of 697 differentially expressed genes after knockdown of NUDT21 in K562 cells. ( B ) Enrichment analysis of differentially expressed genes in GO terms. ( C ) Enrichment analysis of differentially expressed genes in KEGG pathways. ( D ) The histogram showing the relative protein expressions of the key signaling components in K562 cells after transfection of shRNA control or NUDT21 shRNA. Data are expressed as mean ± SD for duplicate experiments. Abbreviations: GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomics.

    Journal: Cancer Management and Research

    Article Title: Knockdown of NUDT21 inhibits proliferation and promotes apoptosis of human K562 leukemia cells through ERK pathway

    doi: 10.2147/CMAR.S173496

    Figure Lengend Snippet: Deregulation of signaling pathways upon knockdown of NUDT21. Notes: ( A ) Heatmap of 697 differentially expressed genes after knockdown of NUDT21 in K562 cells. ( B ) Enrichment analysis of differentially expressed genes in GO terms. ( C ) Enrichment analysis of differentially expressed genes in KEGG pathways. ( D ) The histogram showing the relative protein expressions of the key signaling components in K562 cells after transfection of shRNA control or NUDT21 shRNA. Data are expressed as mean ± SD for duplicate experiments. Abbreviations: GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomics.

    Article Snippet: Specific shRNA plasmid against NUDT21 targeting 5′-ACCTCCTCAGTATCCATAT-3′ and a non-silencing shRNA control plasmid targeting 5′-TTCTCCGAACGT-GTCACGT-3′ were synthesized by Santa Cruz Biotechnology Inc.

    Techniques: Transfection, shRNA

    Potential mechanisms underlying the effects of NUDT21 on K562 cell growth. Notes: ( A ) The protein levels of p-ERK1/2 and PTEN were shown in K562 cells transfected with shRNA control or NUDT21 shRNA using Western blot analysis. ( B ) The mRNA levels of PTEN were compared between K562 cells of shRNA control group and NUDT21 shRNA group using qRT-PCR analysis. ( C ) BrdU incorporation in K562 cells treated with honokiol or control. ( D ) Percentages of cells undergoing apoptosis (annexin V-positive) in different groups were shown. Data are expressed as mean ± SD for duplicate experiments. * P <0.05; ** P <0.01; *** P <0.001. Abbreviations: BrdU, bromodeoxyuridine; PI, propidium iodide; PTEN, phosphatase and tensin homolog deleted on chromosome 10; qRT-PCR, quantitative reverse polymerase chain reaction.

    Journal: Cancer Management and Research

    Article Title: Knockdown of NUDT21 inhibits proliferation and promotes apoptosis of human K562 leukemia cells through ERK pathway

    doi: 10.2147/CMAR.S173496

    Figure Lengend Snippet: Potential mechanisms underlying the effects of NUDT21 on K562 cell growth. Notes: ( A ) The protein levels of p-ERK1/2 and PTEN were shown in K562 cells transfected with shRNA control or NUDT21 shRNA using Western blot analysis. ( B ) The mRNA levels of PTEN were compared between K562 cells of shRNA control group and NUDT21 shRNA group using qRT-PCR analysis. ( C ) BrdU incorporation in K562 cells treated with honokiol or control. ( D ) Percentages of cells undergoing apoptosis (annexin V-positive) in different groups were shown. Data are expressed as mean ± SD for duplicate experiments. * P <0.05; ** P <0.01; *** P <0.001. Abbreviations: BrdU, bromodeoxyuridine; PI, propidium iodide; PTEN, phosphatase and tensin homolog deleted on chromosome 10; qRT-PCR, quantitative reverse polymerase chain reaction.

    Article Snippet: Specific shRNA plasmid against NUDT21 targeting 5′-ACCTCCTCAGTATCCATAT-3′ and a non-silencing shRNA control plasmid targeting 5′-TTCTCCGAACGT-GTCACGT-3′ were synthesized by Santa Cruz Biotechnology Inc.

    Techniques: Transfection, shRNA, Western Blot, Quantitative RT-PCR, BrdU Incorporation Assay, Polymerase Chain Reaction